|
Roivant Sciences Ltd (NASDAQ: ROIV) |
|
Roivant Sciences Ltd
ROIV's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Roivant Sciences Ltd growth rates, revenue grew
by 154.96 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 81
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.18 %
Roivant Sciences Ltd realized net income compared to net loss a year ago in I. Quarter 2024
• More on ROIV's Growth
|
|
Roivant Sciences Ltd current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Roivant Sciences Ltd PEG ratio is at -0
Company is currently trading with Price to Cash flow multiple of 1.98 in trailing twelve-month period. |
Company |
1.91 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 53.03.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.19.
• More on ROIV's Valuation
|
|
|
|
|
Roivant Sciences Ltd current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Roivant Sciences Ltd PEG ratio is at -0
Company is currently trading with Price to Cash flow multiple of 1.98 in trailing twelve-month period. |
Company |
1.91 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 53.03.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.19.
Roivant Sciences Ltd Price to Book Ratio is at 1.42 lower than Industry Avg. of 78.62. and higher than S&P 500 Avg. of 0.01
• More on ROIV's Valuation
|
|
Roivant Sciences Ltd net profit margin of 104.28 % is currently ranking no. 12 in Major Pharmaceutical Preparations industry, ranking no. 17 in Healthcare sector and number 63 in S&P 500.
• More on ROIV's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com